On September 23, INNODIA will host a public webinar for healthcare professionals, researchers in the field of diabetes, the diabetes community at large and other stakeholders interested in the topic. The webinar will be presented jointly by Prof. Mathieu (KU Leuven) and Prof. Peakman (Sanofi). INNODIA is an Innovative Medicines Initiative project, gathering 40 organisations, bringing their knowledge and experience towards one common goal: “To fight Type 1 Diabetes”.
The webinar will open the annual meeting of the INNODIA and INNODIA HARVEST consortia, which will be followed by the plenary session on the next day (for consortia members only). INNODIA and INNODIA HARVEST are reaching a crucial moment, with four clinical trials up and running, remarkable research results and a high level of collaboration among the partners involved.
The webinar aims to explain what INNODIA does, where the projects are heading and highlight both the Natural History study and the four trials. The projects’ latest data will be presented, as well as the outlook to the near future.
Important milestones to be reached in the upcoming months are the recruitment of 750 newly-diagnosed participants alongside 4,000 unaffected family members. Validation and transfer of novel biomarkers, discovery of integrated signatures of novel biomarkers, but also discovery of neoantigens in T1D and validation of biomarkers from the clinical trials are other objectives.
To register to the webinar, click here.
